Loading clinical trials...
Loading clinical trials...
Phase III Study, Randomized, Multicenter, Evaluating the Efficacy of a Cardiovascular Active Prevention Vs Usual Clinical Practice, on the Morbi-mortality Decrease in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitor
Conditions
Interventions
Optimal medical treatment
usual clinical practice
Locations
1
France
CHU
Angers, France
Start Date
December 20, 2019
Primary Completion Date
April 16, 2024
Completion Date
April 16, 2024
Last Updated
March 17, 2025
NCT06514534
NCT05589896
NCT02790515
NCT01667133
NCT04126707
Lead Sponsor
University Hospital, Angers
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions